National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$69.95
add to cart

Rights & Permissions

topleft topright

Dietary Reference Intakes for Calcium and Vitamin D (2011)
Food and Nutrition Board (FNB)

Citation Manager

. "Summary Tables: Dietary Reference Intakes." Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press, 2011.

Please select a format:

BibTeX EndNote RefMan


Page
1104
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


DRI Dietary Reference Intakes Calcium Vitamin D

Dietary Reference Intakes (DRIs): Estimated Average Requirements

Food and Nutrition Board, Institute of Medicine, National Academies

Life Stage Group

Calcium (mg/d)

CHO (g/kg/d)

Protein (g/d)

Vit A (μg/d)a

Vit C (mg/d)

Vit D (μg/d)

Vit E (mg/d)b

Thiamin (mg/d)

Riboflavin (mg/d)

Niacin (mg/d)c

Infants

 

 

 

 

 

 

 

 

 

 

0–6 mo

 

 

 

 

 

 

 

 

 

 

6–12 mo

 

 

1.0

 

 

 

 

 

 

 

Children

 

 

 

 

 

 

 

 

 

 

1–3 y

500

100

0.87

210

13

10

5

0.4

0.4

5

4–8 y

800

100

0.76

275

22

10

6

0.5

0.5

6

Males

 

 

 

 

 

 

 

 

 

 

9–13 y

1,100

100

0.76

445

39

10

9

0.7

0.8

9

14–18 y

1,100

100

0.73

630

63

10

12

1.0

1.1

12

19–30 y

800

100

0.66

625

75

10

12

1.0

1.1

12

31–50 y

800

100

0.66

625

75

10

12

1.0

1.1

12

51–70 y

800

100

0.66

625

75

10

12

1.0

1.1

12

> 70 y

1,000

100

0.66

625

75

10

12

1.0

1.1

12

Females

 

 

 

 

 

 

 

 

 

 

9–13 y

1,100

100

0.76

420

39

10

9

0.7

0.8

9

14–18 y

1,100

100

0.71

485

56

10

12

0.9

0.9

11

19–30 y

800

100

0.66

500

60

10

12

0.9

0.9

11

31–50 y

800

100

0.66

500

60

10

12

0.9

0.9

11

51–70 y

1,000

100

0.66

500

60

10

12

0.9

0.9

11

> 70 y

1,000

100

0.66

500

60

10

12

0.9

0.9

11

Pregnancy

 

 

 

 

 

 

 

 

 

 

14–18 y

1,000

135

0.88

530

66

10

12

1.2

1.2

14

19–30 y

800

135

0.88

550

70

10

12

1.2

1.2

14

31–50 y

800

135

0.88

550

70

10

12

1.2

1.2

14

Lactation

 

 

 

 

 

 

 

 

 

 

14–18 y

1,000

160

1.05

885

96

10

16

1.2

1.3

13

19–30 y

800

160

1.05

900

100

10

16

1.2

1.3

13

31–50 y

800

160

1.05

900

100

10

16

1.2

1.3

13

NOTE: An Estimated Average Requirement (EAR) is the average daily nutrient intake level estimated to meet the requirements of half of the healthy individuals in a group. EARs have not been established for vitamin K, pantothenic acid, biotin, choline, chromium, fluoride, manganese, or other nutrients not yet evaluated via the DRI process.

aAs retinol activity equivalents (RAEs). 1 RAE = 1 μg retinol, 12 μg β-carotene, 24 μg α-carotene, or 24 μg β-cryptoxanthin. The RAE for dietary provitamin A carotenoids is two-fold greater than retinol equivalents (RE), whereas the RAE for preformed vitamin A is the same as RE.

bAs α-tocopherol. α-tocopherol includes RRR-α-tocopherol, the only form of α-tocopherol that occurs naturally in foods, and the 2R-stereoisomeric forms of α-tocopherol (RRR-, RSR-, RRS-, and RSS-α-tocopherol) that occur in fortified foods and supplements. It does not include the 2S-stereoisomeric forms of α-tocopherol (SRR-, SSR-, SRS-, and SSS-α-tocopherol), also found in fortified foods and supplements.

Page
1104
Front Matter (R1-R16)
Summary (1-14)
1 Introduction (15-34)
2 Overview of Calcium (35-74)
3 Overview of Vitamin D (75-124)
4 Review of Potential Indicators of Adequacy and Selection of Indicators: Calcium and Vitamin D (125-344)
5 Dietary Reference Intakes for Adequacy: Calcium and Vitamin D (345-402)
6 Tolerable Upper Intake Levels: Calcium and Vitamin D (403-456)
7 Dietary Intake Assessment (457-478)
8 Implications and Special Concerns (479-512)
9 Information Gaps and Research Needs (513-522)
Appendix A: Acronyms, Abbreviations, and Glossary (523-536)
Appendix B: Issues and Interests Identified by Study Sponsors (537-538)
Appendix C: Methods and Results from the AHRQ-Ottawa Evidence-Based Report on Effectiveness and Safety of Vitamin D in Relation to Bone Health (539-724)
Appendix D: Methods and Results from the AHRQ-Tufts Evidence-Based Report on Vitamin D and Calcium (725-1012)
Appendix E: Literature Search Strategy (1013-1018)
Appendix F: Evidence Maps (1019-1024)
Appendix G: Cases Studies of Vitamin D Toxicity (1025-1034)
Appendix H: Estimated Intakes of Calcium and Vitamin D from National Surveys (1035-1044)
Appendix I: Proportion of the Population Above and Below 40 nmol/L Serum 25-Hydroxyvitamin D Concentrations and Cumulative Distribution of Serum 25-Hydroxyvitamin D Concentrations: United States and Canada (1045-1058)
Appendix J: Workshop Agenda and Open Session Agendas (1059-1064)
Appendix K: Biographical Sketches of Committee Members (1065-1074)
Index (1075-1102)
Summary Tables: Dietary Reference Intakes (1103-1116)